Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Chitosan-glucan complex hollow fibers reinforced collagen wound dressing embedded with aloe vera. Part I: Preparation and characterization.

Abdel-Mohsen AM, Abdel-Rahman RM, Kubena I, Kobera L, Spotz Z, Zboncak M, Prikryl R, Brus J, Jancar J.

Carbohydr Polym. 2020 Feb 15;230:115708. doi: 10.1016/j.carbpol.2019.115708. Epub 2019 Dec 5.

PMID:
31887955
2.

Effect of Selected Commercial Plasticizers on Mechanical, Thermal, and Morphological Properties of Poly(3-hydroxybutyrate)/Poly(lactic acid)/Plasticizer Biodegradable Blends for Three-Dimensional (3D) Print.

Menčík P, Přikryl R, Stehnová I, Melčová V, Kontárová S, Figalla S, Alexy P, Bočkaj J.

Materials (Basel). 2018 Oct 3;11(10). pii: E1893. doi: 10.3390/ma11101893.

3.

Protective Properties of a Microstructure Composed of Barrier Nanostructured Organics and SiOx Layers Deposited on a Polymer Matrix.

Prikryl R, Otrisal P, Obsel V, Svorc L, Karkalic R, Buk J.

Nanomaterials (Basel). 2018 Aug 31;8(9). pii: E679. doi: 10.3390/nano8090679.

4.

Cognitive impairment and cortisol levels in first-episode schizophrenia patients.

Havelka D, Prikrylova-Kucerova H, Prikryl R, Ceskova E.

Stress. 2016 Jul;19(4):383-9. doi: 10.1080/10253890.2016.1193146. Epub 2016 Jun 20.

PMID:
27320489
5.

Semi-continuous ultrasonic sounding and changes of ultrasonic signal characteristics as a sensitive tool for the evaluation of ongoing microstructural changes of experimental mortar bars tested for their ASR potential.

Lokajíček T, Kuchařová A, Petružálek M, Šachlová Š, Svitek T, Přikryl R.

Ultrasonics. 2016 Sep;71:40-50. doi: 10.1016/j.ultras.2016.05.012. Epub 2016 May 20.

PMID:
27268163
6.

Microscopy and Cathodoluminescence Spectroscopy Characterization of Quartz Exhibiting Different Alkali-Silica Reaction Potential.

Kuchařová A, Götze J, Šachlová Š, Pertold Z, Přikryl R.

Microsc Microanal. 2016 Feb;22(1):189-98. doi: 10.1017/S1431927615015524. Epub 2016 Jan 21.

PMID:
26790877
7.

Gender differences in the treatment of first-episode schizophrenia: Results from the European First Episode Schizophrenia Trial.

Ceskova E, Prikryl R, Libiger J, Svancara J, Jarkovsky J.

Schizophr Res. 2015 Dec;169(1-3):303-307. doi: 10.1016/j.schres.2015.10.013. Epub 2015 Nov 3.

PMID:
26545298
8.

Intensive high-frequency repetitive transcranial magnetic stimulation in schizophrenia: a case study.

Sverak T, Prikryl R, Mayerova M, Anderkova L.

J ECT. 2014 Dec;30(4):e51-3. doi: 10.1097/YCT.0000000000000178. No abstract available.

PMID:
25181021
9.

Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients.

Prikryl R, Ustohal L, Kucerova HP, Kasparek T, Jarkovsky J, Hublova V, Vrzalova M, Ceskova E.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:30-5. doi: 10.1016/j.pnpbp.2013.10.019. Epub 2013 Nov 6.

PMID:
24211840
10.

Severe acute dystonia/akathisia after paliperidone palmitate application--a case study.

Ustohal L, Prikryl R, Hublova V, Mayerova M, Kucerova HP, Ceskova E, Kasparek T.

Int J Neuropsychopharmacol. 2014 Feb;17(2):341-2. doi: 10.1017/S1461145713001260. Epub 2013 Oct 24. No abstract available.

PMID:
24152696
11.

A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: a double-blind trial.

Prikryl R, Ustohal L, Prikrylova Kucerova H, Kasparek T, Venclikova S, Vrzalova M, Ceskova E.

Schizophr Res. 2013 Sep;149(1-3):167-73. doi: 10.1016/j.schres.2013.06.015. Epub 2013 Jun 25.

PMID:
23810122
12.

Prevalence of remission and recovery in schizophrenia in the Czech Republic.

Prikryl R, Kholova M, Kucerova HP, Ceskova E.

Compr Psychiatry. 2013 Oct;54(7):1111-6. doi: 10.1016/j.comppsych.2013.05.006. Epub 2013 Jun 27.

PMID:
23810077
13.

Brain functional connectivity of male patients in remission after the first episode of schizophrenia.

Kasparek T, Prikryl R, Rehulova J, Marecek R, Mikl M, Prikrylova H, Vanicek J, Ceskova E.

Hum Brain Mapp. 2013 Mar;34(3):726-37.

PMID:
23520601
14.

Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia?

Prikryl R, Kucerova HP.

J ECT. 2013 Mar;29(1):67-74. doi: 10.1097/YCT.0b013e318270295f. Review.

PMID:
23303418
15.

Role of long-acting injectable second-generation antipsychotics in the treatment of first-episode schizophrenia: a clinical perspective.

Přikryl R, Přikrylová Kučerová H, Vrzalová M, Cešková E.

Schizophr Res Treatment. 2012;2012:764769. doi: 10.1155/2012/764769. Epub 2012 May 7.

16.

Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia.

Prikryl R, Ceskova E, Tronerova S, Kasparek T, Kucerova HP, Ustohal L, Venclikova S, Vrzalova M.

Psychiatry Res. 2012 Dec 30;200(2-3):67-72. doi: 10.1016/j.psychres.2012.03.008. Epub 2012 Apr 10.

PMID:
22494706
17.

Does repetitive transcranial magnetic stimulation have a positive effect on working memory and neuronal activation in treatment of negative symptoms of schizophrenia?

Prikryl R, Mikl M, Prikrylova Kucerová H, Ustohal L, Kasparek T, Marecek R, Vrzalova M, Ceskova E, Vanicek J.

Neuro Endocrinol Lett. 2012;33(1):90-7.

PMID:
22467118
18.

Emotional side effects after high-frequency rTMS of the right dorsolateral prefrontal cortex in an adult patient with ADHD and comorbid depression.

Ustohal L, Prikryl R, Kucerova HP, Sisrova M, Stehnova I, Venclikova S, Vrzalova M, Ceskova E.

Psychiatr Danub. 2012 Mar;24(1):102-3. No abstract available.

19.

Importance of gender in the treatment of schizophrenia.

Ceskova E, Prikryl R.

Prim Care Companion CNS Disord. 2012;14(6). pii: PCC.12m01407. doi: 10.4088/PCC.12m01407. Epub 2012 Nov 15.

20.

Occurrence of robust psychotic symptoms after initial rTMS treatment session.

Prikryl R, Ustohal L, Prikrylova-Kucerova H, Ceskova E.

J ECT. 2011 Sep;27(3):265-6. doi: 10.1097/YCT.0b013e3181f665bc. No abstract available.

PMID:
21865962
21.
22.

Maximum-uncertainty linear discrimination analysis of first-episode schizophrenia subjects.

Kasparek T, Thomaz CE, Sato JR, Schwarz D, Janousova E, Marecek R, Prikryl R, Vanicek J, Fujita A, Ceskova E.

Psychiatry Res. 2011 Mar 31;191(3):174-81. doi: 10.1016/j.pscychresns.2010.09.016. Epub 2011 Feb 4.

PMID:
21295452
23.

Suicides in males after the first episode of schizophrenia.

Ceskova E, Prikryl R, Kasparek T.

J Nerv Ment Dis. 2011 Jan;199(1):62-4. doi: 10.1097/NMD.0b013e31820448e4.

PMID:
21206250
24.

Outcome in males with first-episode schizophrenia: 7-year follow-up.

Ceskova E, Prikryl R, Kasparek T.

World J Biol Psychiatry. 2011 Feb;12(1):66-72. doi: 10.3109/15622975.2010.518625. Epub 2010 Nov 18.

PMID:
21087079
25.

Amisulpride therapeutic dose-induced asymptomatic bradycardia.

Prikryl R, Ustohal L, Prikrylova-Kucerova H.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):290. doi: 10.1016/j.pnpbp.2010.10.006. Epub 2010 Oct 19. No abstract available.

PMID:
20965224
26.

Aberrant EEG responses to gamma-frequency visual stimulation in schizophrenia.

Riečanský I, Kašpárek T, Rehulová J, Katina S, Přikryl R.

Schizophr Res. 2010 Dec;124(1-3):101-9. doi: 10.1016/j.schres.2010.06.022. Epub 2010 Aug 9.

PMID:
20692124
27.

Effect of electroconvulsive therapy on cortical excitability in a patient with long-term remission of schizophrenia: a transcranial magnetic stimulation study.

Přikryl R, Ustohal L, Kucerová HP, Cesková E.

J ECT. 2011 Mar;27(1):e9-11. doi: 10.1097/YCT.0b013e3181dbf785.

PMID:
20386112
28.

A118G polymorphism of OPRM1 gene is associated with schizophrenia.

Serý O, Prikryl R, Castulík L, St'astný F.

J Mol Neurosci. 2010 May;41(1):219-22. doi: 10.1007/s12031-010-9327-z. Epub 2010 Jan 29.

PMID:
20112002
29.

Prolactin levels in risperidone treatment of first-episode schizophrenia.

Češková E, Přikryl R, Kašpárek T, Ondrušová M.

Int J Psychiatry Clin Pract. 2010;8(1):31-36. doi: 10.1080/1365150031004786.

PMID:
28621165
30.

Paliperidon mediated modification of cortical inhibition.

Prikryl R, Ustohal L, Kucerova HP, Ceskova E.

Neuro Endocrinol Lett. 2009;30(3):396-9.

PMID:
19855366
31.

Source-based morphometry of gray matter volume in men with first-episode schizophrenia.

Kaspárek T, Marecek R, Schwarz D, Prikryl R, Vanícek J, Mikl M, Cesková E.

Hum Brain Mapp. 2010 Feb;31(2):300-10. doi: 10.1002/hbm.20865.

PMID:
19777553
32.

Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients.

Kasparek T, Prikryl R, Schwarz D, Kucerova H, Marecek R, Mikl M, Vanicek J, Ceskova E.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1438-46. doi: 10.1016/j.pnpbp.2009.07.025. Epub 2009 Aug 6.

PMID:
19647777
33.

Raman spectral characterization of dispersed carbonaceous matter in decorative crystalline limestones.

Jehlicka J, Stastná A, Prikryl R.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 Aug;73(3):404-9. doi: 10.1016/j.saa.2008.09.006. Epub 2008 Oct 8.

PMID:
19062335
34.

Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia.

Kaspárek T, Prikryl R, Schwarz D, Tronerová S, Cesková E, Mikl M, Vanícek J.

World J Biol Psychiatry. 2009;10(4 Pt 3):752-62. doi: 10.1080/15622970701882433.

PMID:
18609414
35.

Psychopathology and treatment responsiveness of patients with first-episode schizophrenia.

Cesková E, Prikryl R, Kaspárek T, Ondrusová M.

Neuropsychiatr Dis Treat. 2005 Jun;1(2):179-85.

36.

Insight in first-episode schizophrenia.

Cešková E, Přikryl R, Kašpárek T, Kučcerová H.

Int J Psychiatry Clin Pract. 2008;12(1):36-40. doi: 10.1080/13651500701422622.

PMID:
24916495
37.

The influence of temperature and hydration on the sorption properties of bentonite.

Vinsová H, Jedináková-Krízová V, Kolaríková I, Adamcová J, Prikryl R, Zeman J.

J Environ Radioact. 2008 Feb;99(2):415-25. Epub 2007 Dec 21.

PMID:
18155330
38.

A putative DRD3 schizophrenia risk haplotype deconstructed.

Sand PG, Langguth B, Prikryl R, Kucerova H, Ceskova E.

Biol Psychiatry. 2008 Feb 1;63(3):e21; author reply e23-5. Epub 2007 Dec 19. No abstract available.

PMID:
18068689
39.

Testosterone in first-episode schizophrenia.

Cesková E, Prikryl R, Kaspárek T.

Neuro Endocrinol Lett. 2007 Dec;28(6):811-4.

PMID:
18063925
40.

Repetitive transcranial magnetic stimulation as new technique for treatment of negative symptoms of schizophrenia.

Prikryl R, Kucerova H.

Acta Psychiatr Scand. 2008 Jan;117(1):78-9; author reply 79. Epub 2007 Oct 17. No abstract available.

PMID:
17941965
41.

Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study.

Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E.

Schizophr Res. 2007 Sep;95(1-3):151-7. Epub 2007 Aug 8. Erratum in: Schizophr Res. 2008 Feb;99(1-3):380-1.

PMID:
17689931
42.

Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia.

Prikryl R, Ceskova E, Kasparek T, Kucerova H.

Eur Psychiatry. 2007 Nov;22(8):499-504. Epub 2007 Jul 5.

PMID:
17614262
43.

[Cognitive functions impairment in diabetes mellitus patient].

Prikryl R.

Cas Lek Cesk. 2007;146(5):434-7; discussion 438-9. Review. Czech.

PMID:
17554964
44.

Processes affecting oxygen isotope ratios of atmospheric and ecosystem sulfate in two contrasting forest catchments in Central Europe.

Novák M, Mitchell MJ, Jacková I, Buzek F, Schweigstillová J, Erbanová L, Prikryl R, Fottová D.

Environ Sci Technol. 2007 Feb 1;41(3):703-9.

PMID:
17328173
45.

Influencing negative symptoms of schizophrenia with repetitive transcranial magnetic stimulation: a case study.

Prikryl R, Skotakova S, Kasparek T, Ceskova E, Kucerova H, Ustohal L.

Acta Neuropsychiatr. 2007 Feb;19(1):53-5. doi: 10.1111/j.1601-5215.2006.00166.x.

PMID:
26952798
46.

Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia.

Kaspárek T, Prikryl R, Mikl M, Schwarz D, Cesková E, Krupa P.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):151-7. Epub 2006 Sep 29.

PMID:
17011096
47.

[Hippocampus, structure of the brain and schizophrenia].

Kaspárek T, Prikryl R, Schwarz D, Kucerová H, Cesková E.

Cas Lek Cesk. 2006;145(7):544-7; discussion 548. Review. Czech.

PMID:
16921782
48.

Dexamethasone suppression test in first-episode schizophrenia.

Cesková E, Kaspárek T, Zourková A, Prikryl R.

Neuro Endocrinol Lett. 2006 Aug;27(4):433-7.

PMID:
16892008
49.

Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia.

Sand P, Langguth B, Hajak G, Perna M, Prikryl R, Kucerova H, Ceskova E, Kick C, Stoertebecker P, Eichhammer P.

Schizophr Res. 2006 Feb 28;82(2-3):277-8. Epub 2005 Dec 27. No abstract available.

PMID:
16377159
50.

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia.

Prikryl R, Ceskova E, Kasparek T, Kucerova H.

J Psychiatr Res. 2006 Mar;40(2):141-6.

PMID:
15907940

Supplemental Content

Loading ...
Support Center